Normal Tension Glaucoma (NTG)

3

Review clinical trials related to Normal Tension Glaucoma (NTG). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG

Participants needed: 14
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Qlaris Bio, Inc.Updated: Feb 24, 2026Locations: 1
Eligibility criteria

Diagnosis of mild to moderate OAG, mild to moderate NTG, or stable NPDR in at le... [+2]

History of active ocular disease other than mild to moderate OAG, mild to modera... [+8]

Status: Not yet recruiting

DSLT in Normal Tension Glaucoma (NTG) Asian Eyes

The goal of this clinical trial is to evaluate the efficacy of direct selective laser trabeculoplasty (DSLT) or laser treatment in Asian patients with normal tension glaucoma. The main question it aims to answer is: Does the DSLT reduce intraocular pressure (IOP) and medication use in Asian NTG subjects? Participants will attend routine follow-up visits with their eye surgeon and glaucoma testing such as optical coherence tomography (OCT) imaging and visual field test(s) after the laser study treatment.

Participants needed: 40
Trial details
Age: 20+Biological sex: AllType: InterventionalSponsor: Ngoc Nguyen Inc.Updated: Dec 24, 2025Locations: 1
Eligibility criteria

Asian descent [+8]

Angle closure glaucoma or narrow angle status post laser peripheral iridotomy (L... [+5]

Status: Not yet recruiting

Optic Nerve Head Evaluation Through Multimodal Blood Flow Analysis: a Prospective Observational, Multi-center Study

OCT-A and eco-colordoppler are technologies which enable optic nerve head (ONH) blood perfusion detection. The aim of the study is to assess ONH vascular and structural components in optic neuropathies with and without ONH edema or pseudo-edema with OCT-A, and analyze ONH blood-flow with eco-colordoppler.

Participants needed: 70
Trial details
Age: 12+Biological sex: AllType: ObservationalSponsor: BarboniUpdated: Jul 20, 2025
Eligibility criteria

Participant (or parents/legal representative/tutor for minors) is willing and ab... [+4]

any other ONH disease or neurological /retinal disease impairing the evaluation... [+2]